Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€21.62

€21.62

-3.520%
-0.79
-3.520%
€52.27
 
03.02.26 / Tradegate WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Hims & Hers Health Inc. Stock

Heavy losses for Hims & Hers Health Inc. today as the stock fell by -€0.790 (-3.520%).
With 14 Buy predictions and 12 Sell predictions the community is currently undecided on Hims & Hers Health Inc..
Based on the current price of 21.62 € the target price of 52 € shows a potential of 140.52% for Hims & Hers Health Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Hims & Hers Health Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Debt" there were negative voices in the community.

Pros and Cons of Hims & Hers Health Inc. in the next few years

Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financial outlook for Hims & Hers Health (symbol: HIMS) presents an interesting tableau that mirrors the evolving landscape of the healthcare industry, particularly in the realm of telehealth and wellness services. At first glance, the company’s financials reflect both the potential for growth and the challenges that come with it. While the revenue growth shows promise, the profitability metrics raise some eyebrows. Here's a deeper dive into the pros and cons of the company's financial position.

1. Revenue Growth and Market Presence:

Hims & Hers has demonstrated impressive revenue growth, with a year-over-year quarterly revenue increase of approximately 45.8%. This growth trajectory signifies a strong market presence and an escalating demand for its digital health solutions. The total revenue stands at $959.4 million, highlighting the company’s ability to attract and retain a growing customer base in a competitive market.

Comments

Prediction Buy
Perf. (%) -5.55%
Target price 50.532
Change
Ends at 02.02.27

Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at BTIG Research from $85.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

Hims & Hers Health (NYSE:HIMS) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for HIMS provided by MarketBeat
Show more

Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Show more